Peel Hunt reaffirmed their buy rating on shares of ConvaTec Group (LON:CTEC) in a research report sent to investors on Wednesday, LSE.Co.UK reports. Peel Hunt currently has a GBX 280 ($3.66) price target on the stock.
Other equities analysts have also recently issued research reports about the stock. UBS Group lifted their target price on shares of ConvaTec Group from GBX 129 ($1.69) to GBX 185 ($2.42) and gave the stock a neutral rating in a research report on Tuesday, August 6th. Deutsche Bank restated a sell rating on shares of ConvaTec Group in a research report on Friday, July 12th. JPMorgan Chase & Co. boosted their price objective on shares of ConvaTec Group from GBX 132 ($1.72) to GBX 174 ($2.27) and gave the company a neutral rating in a research report on Monday, August 5th. Finally, Peel Hunt restated a buy rating and issued a GBX 280 ($3.66) price objective on shares of ConvaTec Group in a research report on Wednesday. One research analyst has rated the stock with a sell rating, five have given a hold rating and five have assigned a buy rating to the company’s stock. The company currently has a consensus rating of Hold and an average target price of GBX 179.36 ($2.34).
Shares of LON:CTEC opened at GBX 178.70 ($2.34) on Wednesday. The stock has a market cap of $3.53 billion and a PE ratio of 22.34. The company’s fifty day moving average is GBX 176.50 and its 200 day moving average is GBX 149.58. ConvaTec Group has a 52 week low of GBX 113.25 ($1.48) and a 52 week high of GBX 240.50 ($3.14). The company has a quick ratio of 1.58, a current ratio of 2.37 and a debt-to-equity ratio of 104.76.
ConvaTec Group Company Profile
ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of chronic wounds resulting from various conditions, such as diabetes, immobility, and venous disease, as well as for traumatic injury, burns, invasive surgery, and other causes.
Further Reading: Bar Chart
Receive News & Ratings for ConvaTec Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group and related companies with MarketBeat.com's FREE daily email newsletter.